Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jürgen Handler"'
Publikováno v:
Breast Cancer Research and Treatment
Rose, M, Svensson, H, Handler, J, Hoyer, U, Ringberg, A & Manjer, J 2020, ' Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer ', Breast Cancer Research and Treatment, vol. 180, no. 1, pp. 247-256 . https://doi.org/10.1007/s10549-020-05544-2
Rose, M, Svensson, H, Handler, J, Hoyer, U, Ringberg, A & Manjer, J 2020, ' Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer ', Breast Cancer Research and Treatment, vol. 180, pp. 247-256 . https://doi.org/10.1007/s10549-020-05544-2
Rose, M, Svensson, H, Handler, J, Hoyer, U, Ringberg, A & Manjer, J 2020, ' Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer ', Breast Cancer Research and Treatment, vol. 180, no. 1, pp. 247-256 . https://doi.org/10.1007/s10549-020-05544-2
Rose, M, Svensson, H, Handler, J, Hoyer, U, Ringberg, A & Manjer, J 2020, ' Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer ', Breast Cancer Research and Treatment, vol. 180, pp. 247-256 . https://doi.org/10.1007/s10549-020-05544-2
Introduction Oncoplastic breast surgery (OBS) has developed as an extension of breast-conserving surgery (BCS) in an effort to improve esthetic and functional outcome following surgery for breast cancer. The aim of the present study was to evaluate t
Publikováno v:
Rose, M, Svensson, H, Handler, J, Hoyer, U, Ringberg, A & Manjer, J 2019, ' Oncoplastic Breast Surgery Compared to Conventional Breast-Conserving Surgery With Regard to Oncologic Outcome ', Clinical Breast Cancer, vol. 19, no. 6, pp. 423-432.e5 . https://doi.org/10.1016/j.clbc.2019.05.016
INTRODUCTION: Oncoplastic breast surgery (OBS) has been implemented with increasing frequency in the treatment of breast cancer. The aim of this study was to compare the oncologic outcome after OBS to the outcome after conventional breast-conserving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471b41afac458e2d7beb083b5e4df874
https://vbn.aau.dk/da/publications/15a64409-7bd7-4240-8e4a-5a7f466d3ae7
https://vbn.aau.dk/da/publications/15a64409-7bd7-4240-8e4a-5a7f466d3ae7
Autor:
Maj-Britt Jensen, Bo Grundtmann, Peer Christiansen, Anne Vibeke Lænkholm, Tove Filtenborg Tvedskov, Ann Knoop, Signe Korsgaard Skriver, Birgitte Bruun Rasmussen, Jürgen Handler, Bent Ejlertsen
Publikováno v:
Skriver, S K, Laenkholm, A-V, Rasmussen, B B, Handler, J, Grundtmann, B, Tvedskov, T F, Christiansen, P, Knoop, A S, Jensen, M-B & Ejlertsen, B 2018, ' Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG) ', Acta Oncologica, vol. 57, pp. 1-7 . https://doi.org/10.1080/0284186X.2017.1401228
INTRODUCTION: Neoadjuvant endocrine treatment (NET) is a low-toxicity approach to achieve operability in locally advanced breast cancer, and to facilitate breast conservation in early breast cancer, particular in patients with highly estrogen recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04cf3ecf5be74027a71b12f95d3263aa
https://pure.au.dk/portal/da/publications/neoadjuvant-letrozole-for-postmenopausal-estrogen-receptorpositive-her2negative-breast-cancer-patients-a-study-from-the-danish-breast-cancer-cooperative-group-dbcg(00e87aba-9155-43c4-aa58-bd0b14890dc5).html
https://pure.au.dk/portal/da/publications/neoadjuvant-letrozole-for-postmenopausal-estrogen-receptorpositive-her2negative-breast-cancer-patients-a-study-from-the-danish-breast-cancer-cooperative-group-dbcg(00e87aba-9155-43c4-aa58-bd0b14890dc5).html
Autor:
Skriver, Signe Korsgaard1 signe.korsgaard.skriver@regionh.dk, Laenkholm, Anne-Vibeke2, Rasmussen, Birgitte Bruun3, Handler, Jürgen4, Grundtmann, Bo5, Tvedskov, Tove Filtenborg6, Christiansen, Peer7, Knoop, Ann S.1, Jensen, Maj-Britt8, Ejlertsen, Bent1,8
Publikováno v:
Acta Oncologica. Jan2018, Vol. 57 Issue 1, p31-37. 7p.
Publikováno v:
Breast Cancer Research & Treatment; Feb2020, Vol. 180 Issue 1, p247-256, 10p